453P The value of achieving deep partial response (PR) in the context of long-term outcomes in patients (Pts) with human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (mBC): A DESTINY-breast03 (DB-03) exploratory analysis

ESMO Open 2026 Open access

Read full text
Authors: E.P. Hamilton, J.C. Cortés, Giuseppe Curigliano, Sara A. Hurvitz, S-A. Im, W.T. Pasteiner, S. Nakatani, D. Kile, D. Leung, A. Egorov, H. Iwata
DOI: 10.1016/j.esmoop.2026.107476
Cited by: 1

Fields of Study & Subjects

Advanced Breast Cancer Therapies Breast Cancer Treatment Studies HER2/EGFR in Cancer Research

Publication details

Journal / source
ESMO Open
Publisher
Elsevier BV
Volume
11
Pages
107476–107476
Publication date
1 May 2026
Language
EN